Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28922962 | 1.00 | LMNA (0.59) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL18092218 | 0.93 | LMNA (0.64) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL316430 | 0.91 | LMNA (0.59) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL1782837 | 0.91 | LMNA (0.46) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL276587 | 0.91 | LMNA (0.59) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL231303 | 0.90 | — | — | |
| SCHEMBL21975301 | 0.88 | LMNA (0.64) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL11764950 | 0.86 | LMNA (0.59) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL3408019 | 0.85 | HIF1A (0.45) | LMNABLMALOX15HIF1ATSHR | |
| Propane SCHEMBL1390068 | 0.85 | TSHR (0.50) | LMNABLMHIF1ATSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | claimed |
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-06-25 | — | — | US | claimed |
| EP-2072083-A1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | Symrise GmbH & Co. KG (DE) | 2009-06-24 | — | — | EP | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| EP-1682230-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | Symrise GmbH & Co. KG (DE) | 2006-07-26 | — | — | EP | claimed |
| WO-2005004825-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | claimed |
| CN-106010788-B | Novel aldehyde compounds and their use in perfuming compositions | 国际香料和香精公司 | 2021-04-23 | — | — | CN | disclosed |
| US-10150722-B2 | Aldehyde compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2018-12-11 | — | — | US | disclosed |
| EP-3072876-B1 | ALDEHYDE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INT FLAVORS & FRAGRANCES INC (US) | 2018-10-10 | — | — | EP | disclosed |
| US-20180057436-A1 | NOVEL ALDEHYDE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-03-01 | — | — | US | disclosed |
| US-20180057436-A1 | NOVEL ALDEHYDE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-03-01 | — | — | US | disclosed |
| US-9850191-B2 | Aldehyde compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2017-12-26 | — | — | US | disclosed |
| US-9850191-B2 | Aldehyde compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2017-12-26 | — | — | US | disclosed |
| EP-3072876-A1 | ALDEHYDE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | Closson, Adam P. (US) | 2016-09-28 | — | — | EP | disclosed |
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | disclosed |
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-06-25 | — | — | US | disclosed |
| EP-2072083-A1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | Symrise GmbH & Co. KG (DE) | 2009-06-24 | — | — | EP | disclosed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | disclosed |
| EP-1682230-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | Symrise GmbH & Co. KG (DE) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005004825-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | CYP1B1, CYP4A22, ROS1 | LMNA 4524/4885BLM 4734/4885PTPN1 3247/4885 |
| US-20180057436-A1 | NOVEL ALDEHYDE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | ALDH1A1, TRPA1, ALDH2 | LMNA 4040/4885BLM 4671/4885PTPN1 4833/4885 |
| US-10150722-B2 | Aldehyde compounds and their use in perfume compositions | ALDH1A1, ALDH2, ADH5 | LMNA 3615/4885BLM 4663/4885PTPN1 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.